PatentsUSA
Morrison & Foerster Secures Patent Infringement Victory for NeoGenomics in Cancer Test Kit Dispute with Natera
In a significant patent infringement ruling, Morrison & Foerster successfully defended NeoGenomics' proprietary cancer test kit technology against claims from rival Natera. The legal victory underscores the importance of robust intellectual property protection in the competitive oncology diagnostics market.
Thursday, May 14, 2026